Author:
Nagatsu Toshiharu,Nakashima Akira,Ichinose Hiroshi,Kobayashi Kazuto
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference128 articles.
1. Bademci G, Edwards TL, Torres AL, Scott WK, Züchner S, Martin ER, Vance JM, Wang L (2010) A rare novel mutation of the tyrosine hydroxylase gene in Parkinson disease. Hum Mutat 31(10):E1767–E1771
2. Bademci G, Vance JM, Wang L (2012) Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson’s disease. CNS Neurol Disord Drug Targets 11(4):469–481
3. Barbeau A (1969) l-Dopa therapy in Parkinson’s disease: a critical review of nine years’ experience. Can Med Assoc J 101(13):59–68
4. Bezem MT, Baumann A, Skjærven L, Meyer R, Kursula P, Martinez A, Flydal MI (2016) Stable preparations of tyrosine hydroxylase provide the solution structure of the full-length enzyme. Sci Rep 6:30390
5. Birkmayer W, Hornykiewicz O (1961) Der l-3,4-Dioxyphenylalanin (l-DOPA)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73:787–788
Cited by
126 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献